AMH Equity’s DarioHealth DRIO Stock Holding History

AMH Equity’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,750	Closed	-$144K	–	59
2025 Q2	$144K	Sell	10,750 -1,750	-14%	-$24.3K	0.19%	52
2025 Q1	$153K	Buy	+12,500	New	+$176K	0.23%	49

Other funds holding DRIO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

YDMI

Y.D. More Investments Ramat Gan, Israel $2.55B AUM 104.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lasry Marc $15.1M AUM 10.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

TCOT

Trust Company of Toledo Holland, Ohio $1.2B AUM 33.38% 1-Year Est. Return

AMH Equity's DRIO Position: Q3 2025 in Review

AMH Equity sold out of DarioHealth (DRIO) in Q3 2025, closing a stake of 10,750 shares — an estimated $144K sold.

AMH Equity first reported a position in DRIO in Q1 2025 and held it in 2 quarters. The position peaked at $153K in Q1 2025. 23 funds tracked by Wall St. Rank hold DRIO as of Q3 2025.

AMH Equity reported no remaining DarioHealth position as of Q3 2025 after selling out during the quarter.
AMH Equity sold 10,750 DarioHealth shares in Q3 2025, an estimated $144K.
AMH Equity first reported a position in DarioHealth in Q1 2025 and held it in 2 quarters.
AMH Equity's DarioHealth position peaked at $153K in Q1 2025.
23 funds tracked by Wall St. Rank held DarioHealth as of Q3 2025.

Based on AMH Equity's 13F filing for Q3 2025, filed 29 Oct 2025.